Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis.
Xing GaoHidde C G OvertoomBen M EyckShi-Han HuangDaan NieboerPieter C van der SluisSjoerd M LagardeBas P L WijnhovenYin Kai ChaoJan J B van LanschotPublished in: The British journal of surgery (2024)
The pathological response to neoadjuvant chemoradiotherapy is less favourable in patients treated in Eastern countries compared with Western countries. Despite efforts to investigate accounting factors, the discrepancy in pCR rate cannot be entirely explained by differences in patient, tumour, or treatment characteristics.